Evaxion Biotech A/S (EVAX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 7.49M | 37K | 0 | 122K | 3.02M | 154K | 51K | 73K | 0 | 0 | 0 |
| Revenue Growth % | -100% | 148.33% | -75.97% | -100% | 67.12% | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 7.49M | 37K | 0 | 122K | 3.02M | 154K | 51K | 73K | 0 | 0 | 0 |
| Gross Margin % | - | 100% | 100% | - | 100% | 100% | 100% | 100% | 100% | - | - | - |
| Gross Profit Growth % | -100% | 148.33% | -75.97% | -100% | 67.12% | - | - | - | - | - | - | - |
| Operating Expenses | 4.05M | 4.47M | 4.38M | 3.87M | 4.15M | 4.75M | 4.74M | 4.45M | 4.44M | 5.76M | 5.68M | 6.53M |
| OpEx % of Revenue | - | 59.66% | 11829.73% | - | 3398.36% | 157.37% | 3074.68% | 8719.61% | 6078.08% | - | - | - |
| Selling, General & Admin | 1.19M | 1.38M | 2.21M | 1.71M | 1.59M | 2.13M | 1.98M | 1.61M | 1.86M | 2.93M | 2.74M | 2.45M |
| SG&A % of Revenue | - | 18.38% | 5978.38% | - | 1302.46% | 70.73% | 1287.66% | 3158.82% | 2553.42% | - | - | - |
| Research & Development | 2.56M | 3.09M | 2.17M | 2.16M | 2.25M | 2.61M | 2.75M | 2.84M | 2.3M | 2.83M | 2.94M | 3.85M |
| R&D % of Revenue | - | 41.27% | 5851.35% | - | 1848.36% | 86.64% | 1787.01% | 5560.78% | 3147.95% | - | - | - |
| Other Operating Expenses | 301K | 1K | 0 | 0 | 302K | 0 | 0 | 0 | 275K | 0 | 0 | 221K |
| Operating Income | -4.05M | 3.02M | -4.34M | -3.87M | -4.02M | -1.73M | -4.58M | -4.4M | -4.36M | -5.76M | -5.68M | -6.53M |
| Operating Margin % | - | 40.34% | -11729.73% | - | -3298.36% | -57.37% | -2974.68% | -8619.61% | -5978.08% | - | - | - |
| Operating Income Growth % | -0.7% | 274.58% | 5.26% | 12.01% | 7.79% | 69.96% | 19.31% | 32.63% | 33.12% | 5.28% | 9.3% | -1.97% |
| EBITDA | -8.29M | 5.71M | -4.79M | -1.38M | -3.93M | -1.65M | -6.17M | 1.22M | -4.25M | -5.56M | -5.69M | -6.11M |
| EBITDA Margin % | - | 76.24% | -12932.43% | - | -3223.98% | -54.59% | -4007.79% | 2396.08% | -5820.55% | - | - | - |
| EBITDA Growth % | -110.64% | 446.81% | 22.47% | -212.52% | 7.43% | 70.39% | -8.53% | 120% | 28.64% | -3.38% | -20.49% | -3.89% |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 90.75K | 0 | 0 | 0 | 115K | 200K | 0 | 0 |
| EBIT | -8.29M | 5.71M | -4.79M | -1.38M | -5.61M | -1.65M | -6.17M | 1.22M | -4.59M | -5.69M | -5.69M | -6.11M |
| Net Interest Income | -3.79M | 1.33M | -211K | 2.1M | 119.16K | -300.95K | -184K | 5.37M | -418K | -110K | -174K | -41K |
| Interest Income | -4.91M | 2.69M | 30K | 2.49M | 573.95K | 84.26K | 41K | 5.62M | -250K | 72K | 47K | 285K |
| Interest Expense | -1.12M | 1.36M | 241K | 397K | 454.79K | 385.21K | 225K | 246K | 168K | 182K | 221K | 326K |
| Other Income/Expense | -2.12M | 1.33M | -686K | 2.1M | 120K | -300K | -1.82M | 5.37M | -336K | -110K | -231K | 90K |
| Pretax Income | -6.17M | 4.35M | -5.03M | -1.77M | -3.9M | -2.03M | -6.4M | 976K | -4.7M | -5.87M | -5.91M | -6.43M |
| Pretax Margin % | - | 58.09% | -13583.78% | - | -3200% | -67.32% | -4153.9% | 1913.73% | -6438.36% | - | - | - |
| Income Tax | -256K | -265K | -195K | -192K | -275K | -96K | -199K | -218K | -177K | -194K | -225K | -194K |
| Effective Tax Rate % | 4.15% | -6.09% | 3.88% | 10.84% | 7.04% | 4.73% | 3.11% | -22.34% | 3.77% | 3.3% | 3.81% | 3.01% |
| Net Income | -5.92M | 4.62M | -4.83M | -1.58M | -3.63M | -1.94M | -6.2M | 1.19M | -4.52M | -5.68M | -5.68M | -6.24M |
| Net Margin % | - | 61.64% | -13056.76% | - | -2974.59% | -64.14% | -4024.68% | 2341.18% | -6195.89% | - | - | - |
| Net Income Growth % | -63.08% | 338.66% | 22.06% | -232.33% | 19.77% | 65.92% | -9.06% | 119.13% | 34.18% | 1.08% | -19.19% | -7.77% |
| Net Income (Continuing) | -5.92M | 4.62M | -4.83M | -1.58M | -3.63M | -1.94M | -6.2M | 1.19M | -4.52M | -5.68M | -5.68M | -6.24M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.89 | 4.20 | -4.40 | -0.50 | -3.40 | -1.40 | -4.60 | 1.04 | -6.60 | -8.20 | -8.40 | -9.68 |
| EPS Growth % | 73.82% | 400% | 4.35% | -148.08% | 48.48% | 82.93% | 45.24% | 110.74% | 42.11% | 14.94% | -5% | 3.2% |
| EPS (Basic) | -0.89 | 4.20 | -4.40 | -1.43 | -3.40 | -1.40 | -4.60 | 1.04 | -6.60 | -8.20 | -8.40 | -9.68 |
| Diluted Shares Outstanding | 6.41M | 1.11M | 1.11M | 1.11M | 1.07M | 1.38M | 1.35M | 1.17M | 683.39K | 691.5K | 676.55K | 644.6K |
| Basic Shares Outstanding | 6.41M | 1.11M | 1.11M | 1.11M | 1.07M | 1.38M | 1.35M | 1.17M | 683.39K | 691.5K | 676.55K | 644.6K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |